Malcolm Kendall

Malcolm Kendall has over 28 years of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies. Before founding Microbiome Insights, he was the co-founder and CEO of Indel Therapeutics Inc., a Vancouver-based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. Prior to this, Malcolm was an investment professional with life science focused venture capital firms MDS Capital (now Lumira Capital), BioVista Capital (now Hatteras Venture Partners) and Intersouth Partners. Before entering business, he served in the U.S. Army where he honed his leadership skills as an Infantry and Special Forces officer. Malcolm has been an advisor and board member to numerous companies and organizations and is currently a member of the board of directors of Semios BIO Technologies, a mentor for the entrepreneurship@UBC program and an adjunct professor at the MBA MOT program at Simon Fraser University. He received his undergraduate degree from Washington and Lee University and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.

Education

• Pineland University (1989 — 1989)
• B.A. Washington and Lee University (1979 — 1984)
• High School Durham Academy (1975 — 1979)

Companies

• Business Advisor PanGenomic Health (2021)
• EIR, Investor Readiness Program LifeSciences BC (2020)
• Co-founder & CEO Microbiome Insights Inc. (2014)
• Business Advisory Board Primary Peptides (2021 — 2022)
• Founding Advisor and Board Member Semios Technologies (2010 — 2021)
• Advisor and Investor Sherpa Foods (2016 — 2020)
• Adjunct Professor Segal Business School MBA Program, Simon Fraser University (2006 — 2020)
• Co-founder and CEO Indel Therapeutics Inc. (2007 — 2013)
• Board Member Inimex Pharmaceuticals Inc. (acquired by Soligenix, Inc.) (2004 — 2007)

Skills

• Business Planning
• Science
• Corporate Governance

Other

Competitive Analysis, Valuation, Strategic Partnerships, Investments, Management Consulting, Biopharmaceuticals, Finance, Program Management, Mergers & Acquisitions, Corporate Development, Pharmaceutical Industry, Technology Transfer, Executive Management, Drug Discovery, Management, Due Diligence, Leadership, Strategic Planning, Life Sciences, Business Strategy, Commercialization, Business Development, Lifesciences, Strategy, Biotechnology, Entrepreneurship, Venture Capital, Start-ups